There is no blind faith. There is a Stock jumping from trips to a penny within a short period of time, an announcement made in the shadow of the SEC, that the toxic debt the company had has been absorbed by long-term investors.
Then subsequent announcements, again in the shadow of the SEC, announcing partnerships and funding for phase 3 clinical trials of the company’s main drug.
If you ignore all this, you are the blind one!